Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...

The gene-editing technology has led to innovations in medicine, ... A diagram visualizing the process in which DNA is edited using CRISPR-Cas9. Cas9 enzyme. DNA. Guide RNA. Matching DNA. 1.

While other gene-editing tools are still in use, CRISPR provides a gigantic leap because of its precision and reliability. It's really good at finding genes and making accurate cuts.

The company is on its third CEO since 2019, and its chief scientist departed in January. While most gene-editing stocks have soared in 2021, Editas' shares are down by 43% on the year.

In the last few months, many researchers have come to realize that the new gene editing tool, known as CRISPR/Cas9, might provide an easy means for molding a person when he or she is just a single ...

IN THE EARLY days of gene editing, biologists had a molecular tool kit that was somewhat akin to a printing press. Which is to say, altering DNA was a messy, labor-intensive process of loading ...

Scientists have developed a new gene-editing technology that could potentially correct up to 89% of genetic defects, including those that cause diseases like sickle cell anemia.

For the first time, doctors have created a customized treatment using the revolutionary gene-editing technique known as CRISPR to treat a baby with a rare, life-threatening genetic disorder.

In 2023, we saw the first approval of a CRISPR-based gene-editing therapy. And many more are to come. So let’s take a look at the developments that made news this year.

And 57% of women think it very likely that gene editing will be used in morally unacceptable ways, compared with 51% of men. Men are more inclined than women to expect positive outcomes from the ...